Padagis

ALLEGAN, Mich., June 15, 2023 /PRNewswire/ — Padagis announced today two first-to-file ANDA submissions. Padagis President, Pam Hoffman, stated “The investments in our pipeline made by Padagis since our inception have begun to bear fruit. Two first-to-file ANDA submissions speak to the innovation and execution capabilities of the Padagis team. Most importantly, these achievements are the … Read more

ALLEGAN, Mich., June 9, 2023 /PRNewswire/ — Padagis today announced the launch of Tazarotene Gel (generic to Tazorac® Gel) and Methylphenidate Transdermal System (authorized generic to Daytrana®). Tazorac® Gel 0.05% and 0.1% are indicated for the topical treatment of patients with plaque psoriasis of up to 20% body surface area involvement. Tazorac® Gel 0.1% is … Read more